WHO To Facilitate Rapid Roll Out Of Merck's Ebola Vaccine In Africa
Executive Summary
The World Health Organization is laying down the ground work to ensure that African countries at risk of an Ebola outbreak are able to approve the vaccine for use soon after it is authorized in the EU or the US.
You may also be interested in...
WHO Prequalifies Ebola Vaccine To Speed Up Availability In Africa
Following its recent EU approval, moves are under way to make Merck’s Ervebo vaccine available in countries at risk of Ebola.
Merck's Ebola Vaccine Will Get US FDA Decision Before March Review Deadline
Staffer says agency will make a licensure decision "well ahead" of the March action date; 230,000 have received the vaccine under compassionate use.
First Ebola Vaccine Among Seven Products To Get EMA Nod
Seven new products, including the world’s first ever Ebola vaccine, are on track to receive EU-wide approval. Meanwhile, two drugs have failed to make the grade.